In silico methods in the discovery of endocrine disrupting chemicals

Journal of Steroid Biochemistry and Molecular Biology

Volumn 137, Issue , 2013, Pages 18-26

  Vuorinen, Anna ^a   Odermatt, Alex ^b   Schuster, Daniela ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Case studies; Endocrine disruptors; Virtual screening

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ENDOCRINE DISRUPTOR; ESTROGEN; PROTEIN TYROSINE PHOSPHATASE 1B; TESTOSTERONE;

ANDROGEN METABOLISM; CASE STUDY; CHEMICAL STRUCTURE; COMPUTER MODEL; ENZYME ACTIVITY; HIGH THROUGHPUT SCREENING; HOMEOSTASIS; IN VITRO STUDY; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STEROIDOGENESIS;

CASE STUDIES; ENDOCRINE DISRUPTORS; VIRTUAL SCREENING;

COMPUTER SIMULATION; DRUG DISCOVERY; ENDOCRINE DISRUPTORS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, STEROID;

EID: 84886592000     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.04.009     Document Type: Review

References (63)

1. E. Diamanti-Kandarakis, J.P. Bourguignon, L.C. Giudice, R. Hauser, G.S. Prins, A.M. Soto, R.T. Zoeller, and A.C. Gore Endocrine-disrupting chemicals: an endocrine society scientific statement Endocrine Reviews 30 2009 293 342
2. L.N. Vandenberg, T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs Jr., D.H. Lee, T. Shioda, A.M. Soto, F.S. vom Saal, W.V. Welshons, R.T. Zoeller, and J.P. Myers Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses Endocrine Reviews 33 3 2012 378 455
3. E. Den Hond, and G. Schoeters Endocrine disrupters and human puberty International Journal of Andrology 29 1 2006 264 271 discussion 286-290
4. J.T. Sanderson The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals Toxicological Sciences 94 1 2006 3 21 (Pubitemid 44542325)
5. N. Kalfa, P. Philibert, and C. Sultan Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? International Journal of Andrology 32 3 2009 187 197
6. L. Ye, Z.J. Su, and R.S. Ge Inhibitors of testosterone biosynthetic and metabolic activation enzymes Molecules 16 12 2011 9983 10001
7. K. Yuan, B. Zhao, X.W. Li, G.X. Hu, Y. Su, Y. Chu, B.T. Akingbemi, Q.Q. Lian, and R.S. Ge Effects of phthalates on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities in human and rat testes Chemico-Biological Interactions 195 3 2012 180 188
8. A. Odermatt, C. Gumy, A.G. Atanasov, and A.A. Dzyakanchuk Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance Journal of Steroid Biochemistry and Molecular Biology 102 1-5 2006 222 231 (Pubitemid 44750634)
9. A. Odermatt, and C. Gumy Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals? Biochemical Pharmacology 76 10 2008 1184 1193
10. J. Guo, W. Yuan, L. Qiu, W. Zhu, C. Wang, G. Hu, Y. Chu, L. Ye, Y. Xu, and R.S. Ge Inhibition of human and rat 11beta-hydroxysteroid dehydrogenases activities by bisphenol A Toxicology letters 2012
11. S. De Coster, and N. van Larebeke Endocrine-disrupting chemicals: associated disorders and mechanisms of action Journal of Environment and Public Health 2012 52
12. A. Fucic, M. Gamulin, Z. Ferencic, J. Katic, M.K.v. Krauss, A. Bartonova, and D.F. Merlo Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain Environmental Health 11 2012 S8
13. D.C. Luccio-Camelo, and G.S. Prins Disruption of androgen receptor signaling in males by environmental chemicals The Journal of Steroid Biochemistry and Molecular Biology 127 74-82 2011
14. P. Sohoni, and J.P. Sumpter Several environmental oestrogens are also anti-androgens Journal of Endocrinology 158 1998 327 339 (Pubitemid 28407540)
15. B. Desvergne, J.N. Feige, and C. Casals-Casas PPAR-mediated activity of phthalates: a link to the obesity epidemic? Molecular and Cellular Endocrinology 304 2009 43 48
16. C. Hao, X. Cheng, H. Xia, and X. Ma The endocrine disruptor monoethyl-hexyl-phthalate promotes adipocyte differentiation and induces obesity in mice Bioscience Reports 2012
17. C.A. Frye, G. Calamandrei, L. Calzà, F. Dessi-Fulgheri, M. Fernández, L. Lusani, O. Kah, M. Kajta, Y.L. Page, H.B. Patisaul, A. Venerosi, A.K. Wojtowicz, and G.C. Panzica Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behavious and neuroendocrine systems Journal of Endocrinology 24 2011 144 159
18. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, and J.A. Gustafsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 3 1997 863 870 (Pubitemid 27089735)
19. S. Soriano, P. Alonso-Magdalena, M. Garcia-Arevalo, A. Novials, S.J. Muhammed, A. Salehi, J.A. Gustafsson, I. Quesada, and A. Nadal Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta PLoS One 7 2 2012 e31109
20. V. Delfosse, M. Grimaldi, J.L. Pons, A. Boulahtouf, A. le Maire, V. Cavailles, G. Labesse, W. Bourguet, and P. Balaguer Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes Proceedings of the National Academy of Sciences of the United States of America 109 37 2012 14930 14935
21. W. Mnif, J.M. Pascussi, A. Pillon, A. Escande, A. Bartegi, J.C. Nicolas, V. Cavailles, M.J. Duchesne, and P. Balaguer Estrogens and antiestrogens activate hPXR Toxicology Letters 170 1 2007 19 29 (Pubitemid 46509749)
22. Y. Sui, N. Ai, S.H. Park, J. Rios-Pilier, J.T. Perkins, W.J. Welsh, and C. Zhou Bisphenol A and its analogues activate human pregnane X receptor Environmental Health Perspectives 120 3 2012 399 405
23. A. Riu, M. Grimaldi, A. le Maire, G. Bey, K. Phillips, A. Boulahtouf, E. Perdu, D. Zalko, W. Bourguet, and P. Balaguer Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A Environmental Health Perspectives 119 9 2011 1227 1232
24. A. Riu, A. le Maire, M. Grimaldi, M. Audebert, A. Hillenweck, W. Bourguet, P. Balaguer, and D. Zalko Characterization of novel ligands of ERalpha, ERbeta, and PPARgamma: the case of halogenated bisphenol A and their conjugated metabolites Toxicological Sciences 122 2 2011 372 382
25. J.B. Fini, A. Riu, L. Debrauwer, A. Hillenweck, S. Le Mevel, S. Chevolleau, A. Boulahtouf, K. Palmier, P. Balaguer, J.P. Cravedi, B.A. Demeneix, and D. Zalko Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies Toxicological Sciences 125 2 2012 359 367
26. K. Moriyama, T. Tagami, T. Akamizu, T. Usui, M. Saijo, N. Kanamoto, Y. Hataya, A. Shimatsu, H. Kuzuya, and K. Nakao Thyroid hormone action is disrupted by bisphenol A as an antagonist Journal of Clinical Endocrinology and Metabolism 87 11 2002 5185 5190 (Pubitemid 35316363)
27. E.R. Levin Minireview: extranuclear steroid receptors: roles in modulation of cell functions Molecular Endocrinology 25 3 2011 377 384
28. R.A. Schweizer, A.G. Atanasov, B.M. Frey, and A. Odermatt A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity Molecular and Cellular Endocrinology 212 1-2 2003 41 49 (Pubitemid 37488027)
29. L. Ye, B. Zhao, G. Hu, Y. Chu, and R.S. Ge Inhibition of human and rat testicular steroidogenic enzyme activities by bisphenol A Toxicology letters 207 2 2011 137 142
30. J. Wang, B. Sun, M. Hou, X. Pan, and X. Li The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydyroxysteroid dehydrogenase type 1 in the adipose tissue of children International Journal of Obesity 2012 1 7
31. M.K. Nanjappa, L. Simon, and B.T. Akingbemi The industrial chemical Bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells Biology of Reproduction 86 2012 1 12
32. Y. Tanrikulu, B. Krüger, and E. Proschak The holistic integration of virtual screening in drug discovery Drug Discovery Today 00 2013
33. T.N. Doman, S.L. McGovern, B.J. Witherbee, T.P. Kasten, R. Kurumbail, W.C. Stallings, D.T. Conolly, and B.K. Shoichet Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B Journal of Medicinal Chemistry 45 2002 2213 2221 (Pubitemid 34525801)
34. D. Schuster, M. Spetea, M. Music, S. Rief, M. Fink, J. Kirchmair, J. Schütz, W. Gerhard, T. Langer, H. Stuppner, H. Schmidhammer, and J.M. Rollinger Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors Bioorganic & Medicinal Chemistry 18 2010 5071 5080
35. C.G. Wermuth, C.R. Ganellin, P. Lindberg, and L.A. Mitscher Glossary of terms used in medicinal chemistry (IUPAC recommendations) Pure & Applied Chemistrty 70 1998 1129 1143
36. G. Jones, and P. Willett Docking small-molecule ligands into active sites Current Opinion in Biotechnology 6 1995 652 656
37. T.S. Rush, J.A. Grant, L. Mosyak, and A. Nicholls A shape-based 3-D Scaffold Hopping method and its application to a bacterial protein-protein interaction Journal of Medicinal Chemistry 48 2005 1489 1495 (Pubitemid 40364556)
38. S. Ekins, J. Mestres, and B. Testa In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling British Journal of Pharmacology 152 2007 9 20 (Pubitemid 47339896)
39. M.J. Keiser, B.L. Roth, B.N. Armbruster, P. Ernsberger, J.J. Irwin, and B.K. Shoichet Relating protein pharmacology by ligand chemistry Nature Biotechnology 25 2007 197 206 (Pubitemid 46227119)
40. V. Poroikov, D. Filimonov, A. Lagunin, T. Gloriozova, and A. Zakharov PASS: identification of probable targets and mechanisms of toxicity SAR and QSAR in Environmental Research 18 2007 101 110
41. S. Marchais-Oberwinkler, C. Henn, G. Möller, T. Klein, M. Negri, A. Oster, A. Spadaro, R. Werth, M. Wetzel, K. Xu, M. Frotscher, R.W. Hartmann, and J. Adamski 17b-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development The Journal of Steroid Biochemistry and Molecular Biology 125 2011 66 82
42. L.G. Nashev, D. Schuster, C. Laggner, S. Sodha, T. Langer, G. Wolber, and A. Odermatt The UV-filter benzophenone-1 inhibits 17β-hydroxysteroid dehydrogenase type 3: virtual screening as a strategy to identify potential endocrine disrupting chemicals Biochemical Pharmacology 79 2010 1189 1199
43. L.G. Nashev, A. Vuorinen, L. Praxmarer, B. Chantong, D. Cereghetti, R. Winiger, D. Schuster, and A. Odermatt Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action PLoS One 7 2012 e46958
44. D. Schuster, E.M. Maurer, C. Laggner, L.G. Nashev, T. Wilckens, T. Langer, and A. Odermatt The discovery of new 11β-hydroxysteroid dehydrogenase Type 1 inhibitors by common feature pharmacophore modeling and virtual screening Journal of Medicinal Chemistry 49 2006 3454 3466 (Pubitemid 43904337)
45. H. Liu, E. Papa, and P. Gramatica QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles Chemical Research in Toxicology 19 2006 1540 1548 (Pubitemid 44863497)
46. J. Li, and P. Gramatica Classification and virtual screening of androgen receptor antagonists Journal of Chemical Information and Modeling 50 2010 861 874
47. A. Vedani, M. Smiesko, M. Spreafico, O. Peristera, and M. Dobler VirtualToxLab - in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress report Altex 26 3 2009 167 176
48. C.Y. Wang, N. Ai, S. Arora, E. Erenrich, K. Nagarajan, R. Zauhar, D. Young, and W.J. Welsh Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach Chemical Research in Toxicology 19 2006 1595 1601 (Pubitemid 44975122)
49. J.D. Dearden In silico prediciton of drug toxicity Journal of Computer Aided Molecular Designing 17 2003 119 127
50. D. Schuster, C. Laggner, T.M. Steindl, and T. Langer Development and validation of an in silico p450 profiler based on pharmacophore models Current Drug Discovery Technologies 3 2006 1 48
51. A.R. Leach, V.J. Gillet, R.A. Lewis, and R. Taylor Three-dimensional pharmacophore methods in drug discovery Journal of Medicinal Chemistry 53 2010 539 558
52. S. Weaver, and M.P. Gleeson The importance of the domain of applicability in QSAR modeling Journal of Molecular Graphics and Modelling 26 8 2008 1315 1326
53. M. Hein, D. Zilian, and C.A. Sotriffer Docking compared to 3D-pharmacophores: the scoring function challenge Current Drug Discovery Technologies 7 4 2010 e229 e236
54. A.G. Atanasov, S. Tam, J.M. Rocken, M.E. Baker, and A. Odermatt Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates Biochemical and Biophysical Research Communications 308 2 2003 257 262 (Pubitemid 36939185)
55. A. Meyer, P. Strajhar, C. Murer, T. Da Cunha, and A. Odermatt Species-specific differences in the inhibition of human and zebrafish 11beta-hydroxysteroid dehydrogenase 2 by thiram and organotins Toxicology 301 1-3 2012 72 78
56. C. Gumy, C. Chandsawangbhuwana, A.A. Dzyakanchuk, D.V. Kratschmar, M.E. Baker, and A. Odermatt Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production PLoS ONE 3 10 2008 e3545
57. S. Karabunarliev, O.G. Mekenyan, W. Karcher, C.L. Russom, and S.P. Bradbury Quantum-chemical descriptors for estimating the acute toxicity of electrophiles to the fathed minnow (Pimephales promelas): an analysis based on molecular mechanisms Quantitative Structure-activity Relationships 15 1996 302 310 (Pubitemid 26283517)
58. R.F. Bruns, and I.A. Watson Rules for identifying potentially reactive or promiscuos compounds Journal of Medicinal Chemistry 55 2012 9763 9772
59. N. Sturm, J. Desaphy, R.J. Quinn, D. Rognan, and E. Kellenberger Structural insights into the molecular basis of the ligand promiscuity Journal of Chemical Information and Modeling 52 9 2012 2410 2421
60. G.M. Spitzer, M. Heiss, M. Mangold, P. Markt, J. Kirchmair, G. Wolber, and K.R. Liedl One concept, three implementations of 3D pharmacophore-based virtual screening: distinct coverage of chemical search space Journal of Chemical Information and Modeling 50 2010 1241 1247
61. M.W. Chang, C. Ayeni, S. Breuer, and B.E. Torbett Virtual screening for HIV protease inhibitors: a comparison of AutoDock4 and Vina PLoS One 2 5 2010 e11955
62. F. Ooms Molecular modeling and computer aided drug design. Examples of their application in medicinal chemistry Current Medicinal Chemistry 7 2000 141 158 (Pubitemid 30396444)
63. D. Poirier 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review Expert Opinion on Therapeutic Patents 20 2010 1123 1145